Home › NCT07102550

Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue

Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue: A Prospective Non-Randomized Clinical Trial

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Adults \>/= 18 years old
* Recipient of LDLT

Exclusion Criteria:

* Patients who are deemed unsafe for participation for any reason by our multi-disciplinary liver transplant selection committee.
* Patients \< 18 years old
* Patients who cannot provide informed consent
* Patients receiving deceased donor liver transplants, or who are not undergoing Liver transplant (LT)
* Patients who do not wish to participate
* Children, cognitively-impaired persons, pregnant women, students and house staff under the direct supervision of the investigator are considered vulnerable populations and will, therefore, be excluded from participation.

About the study

The goal of this single armed, non-randomized, pilot study is to demonstrate that placental tissue grafts are safe in living donor liver transplant and assess their impact on biliary outcomes in adults.

What is being tested

• MiMedx AmnioFix (biological)

Sponsor: Choon Hyuck David Kwon · Participants: 40 · Started: Oct 29, 2024

Contact the study team

• Erlind Allkushi · Phone: 2164440223
• Mary Bilancini · Phone: 2164448983

Official record on ClinicalTrials.gov — NCT07102550

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.